GeoVax Labs, Inc. (GOVX)

GeoVax Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8.59	6.45	27.61	11.42	9.88	0.28
Cash & Short-Term Investments	8.59	6.45	27.61	11.42	9.88	0.28
Cash Growth	-32.27%	-76.63%	141.71%	15.58%	3388.30%	9.10%
Receivables	0.55	-	-	0.05	0.18	0.07
Prepaid Expenses	1.73	1.43	1.33	0.16	0.17	0.1
Total Current Assets	10.87	7.89	28.94	11.63	10.24	0.45
Property, Plant & Equipment	0.17	0.21	0.23	0.16	0.15	0.01
Other Long-Term Assets	0.07	1.19	2.17	0.01	0.01	0.01
Total Assets	11.11	9.28	31.35	11.8	10.39	0.47
Accounts Payable	2.15	2.8	1.75	2.06	0.27	0.15
Accrued Expenses	0.46	0.72	3	3.38	0.36	1.85
Current Portion of Long-Term Debt	-	-	-	-	0.18	0.01
Total Current Liabilities	2.61	3.52	4.75	5.44	0.81	2.02
Long-Term Debt	-	-	-	-	0.01	0.03
Other Long-Term Liabilities	-	-	-	2	-	-
Total Liabilities	2.61	3.52	4.75	7.44	0.83	2.04
Common Stock	0.01	0	0	0.01	0	0
Additional Paid-In Capital	129.59	110.13	105	68.73	55.29	39.34
Retained Earnings	-121.09	-104.36	-78.4	-64.38	-45.81	-42.85
Total Common Equity	8.5	5.76	26.6	4.36	9.49	-3.51
Shareholders' Equity	8.5	5.76	26.6	4.36	9.57	-1.57
Total Liabilities & Equity	11.11	9.28	31.35	11.8	10.39	0.47
Total Debt	-	-	-	-	0.2	0.04
Net Cash (Debt)	8.59	6.45	27.61	11.42	9.69	0.24
Net Cash Growth	-32.27%	-76.63%	141.71%	17.95%	3876.11%	-
Net Cash Per Share	2.63	3.55	24.40	28.09	104.99	-
Filing Date Shares Outstanding	6.4	2.17	1.76	0.47	0.42	0.05
Total Common Shares Outstanding	6.4	1.98	1.76	0.43	0.26	-
Working Capital	8.26	4.37	24.19	6.19	9.42	-1.57
Book Value Per Share	1.33	2.91	15.15	10.25	37.14	-
Tangible Book Value	8.5	5.76	26.6	4.36	9.49	-3.51
Tangible Book Value Per Share	1.33	2.91	15.15	10.25	37.14	-
Machinery	-	0.77	0.73	0.59	0.54	0.55
Leasehold Improvements	-	0.12	0.12	0.12	0.12	0.12

Source: S&P Capital IQ. Standard template. Financial Sources.